A major step forward for Australia’s research and innovation ecosystem

Australia’s association with Horizon Europe opens the door to one of the world’s largest and most impactful research programs. For those of us working in precision medicine and translational research, this is more than just access to funding, it’s access to scale, connection, and acceleration.

Why this matters:

• Global-scale collaboration – Translational research depends on large, diverse datasets and multi-site studies. This enables Australian researchers to work seamlessly within international consortia, strengthening evidence and impact.

• Stronger pathways to translation – Horizon Europe is designed to move research from discovery through to clinical application and implementation. That alignment is critical to bridging the gap between lab and patient care.

• Access to advanced infrastructure and expertise – From clinical trial networks to bioinformatics and regulatory frameworks, this creates opportunities to integrate with mature systems that support end-to-end pipelines.

• Increased opportunities for validation and adoption – The ability to test and validate discoveries across broader populations accelerates the journey from promising finding to real-world health impact.

At PrecisionGo, we see this as a powerful opportunity to further connect Australia’s integrated core facilities into global translational pipelines, supporting researchers to take their work further, faster.

This is how we move from excellent science to meaningful outcomes for patients.